Literature DB >> 35348805

N-methyl-D-aspartate receptor antagonism impairs sensory gating in the auditory cortex in response to speech stimuli.

Sara de la Salle1, Joelle Choueiry1,2, Judy McIntosh1, Hayley Bowers3, Vadim Ilivitsky1, Verner Knott4,5.   

Abstract

Deficits in early auditory sensory processing in schizophrenia have been linked to N-methyl-D-aspartate receptor (NMDAR) hypofunction, but the role of NMDARs in aberrant auditory sensory gating (SG) in this disorder is unclear. This study, conducted in 22 healthy humans, examined the acute effects of a subanesthetic dose of the NMDAR antagonist ketamine on SG as measured electrophysiologically by suppression of the P50 event-related potential (ERP) to the second (S2) relative to the first (S1) of two closely paired (500 ms) identical speech stimuli. Ketamine induced impairment in SG indices at sensor (scalp)-level and at source-level in the auditory cortex (as assessed with eLORETA). Together with preliminary evidence of modest positive associations between impaired gating and dissociative symptoms elicited by ketamine, tentatively support a model of NMDAR hypofunction underlying disturbances in auditory SG in schizophrenia.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Auditory sensory gating; N-methyl-D-aspartate receptor (NMDAR); P50 event-related potential (ERP); Schizophrenia; Symptomatology

Mesh:

Substances:

Year:  2022        PMID: 35348805     DOI: 10.1007/s00213-022-06090-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  72 in total

1.  Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG.

Authors:  L D Blumenfeld; B A Clementz
Journal:  Clin Neurophysiol       Date:  2001-09       Impact factor: 3.708

2.  Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats.

Authors:  P C Bickford; K D Wear
Journal:  Brain Res       Date:  1995-12-24       Impact factor: 3.252

3.  Auditory sensory gating in the rat hippocampus: modulation by brainstem activity.

Authors:  P C Bickford; V Luntz-Leybman; R Freedman
Journal:  Brain Res       Date:  1993-04-02       Impact factor: 3.252

4.  Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol.

Authors:  L E Adler; G Rose; R Freedman
Journal:  Biol Psychiatry       Date:  1986-07       Impact factor: 13.382

5.  Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.

Authors:  Peter H Boeijinga; L Soufflet; F Santoro; R Luthringer
Journal:  J Psychopharmacol       Date:  2007-05       Impact factor: 4.153

6.  Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia.

Authors:  Jefferson Becker; Irenio Gomes; Eduardo S Ghisolfi; Alice Schuch; Fernanda L Paula Ramos; João Arthur Ehlers; Daniel B Nora; Diogo R Lara; Jaderson C da Costa
Journal:  Clin Neurophysiol       Date:  2004-02       Impact factor: 3.708

7.  Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients.

Authors:  Nashaat N Boutros; Oleg Korzyukov; Ben Jansen; Alan Feingold; Morris Bell
Journal:  Psychiatry Res       Date:  2004-05-30       Impact factor: 3.222

8.  Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.

Authors:  Laura C Amann; Tobias B Halene; Richard S Ehrlichman; Stephen N Luminais; Nan Ma; Ted Abel; Steven J Siegel
Journal:  Neurobiol Dis       Date:  2009-05-23       Impact factor: 5.996

9.  Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients.

Authors:  Nash N Boutros; Anke Brockhaus-Dumke; Klevest Gjini; Andrei Vedeniapin; Mohamad Elfakhani; Scott Burroughs; Matcheri Keshavan
Journal:  Schizophr Res       Date:  2009-06-12       Impact factor: 4.939

10.  Meta-analysis of the P300 and P50 waveforms in schizophrenia.

Authors:  Elvira Bramon; Sophia Rabe-Hesketh; Pak Sham; Robin M Murray; Sophia Frangou
Journal:  Schizophr Res       Date:  2004-10-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.